H & C Healthcare Limited

(Registration number: SC740801)
Balance Sheet as at 31 May 2025

	Note	2025 £	2024 £
Fixed assets
Intangible assets	5	1,071,452	1,151,502
Tangible assets	6	104,851	119,150
		1,176,303	1,270,652
Current assets
Stocks	7	108,891	48,922
Debtors	8	178,347	168,595
Cash at bank and in hand		370,069	141,419
		657,307	358,936
Creditors: Amounts falling due within one year	9	(900,913)	(758,486)
Net current liabilities		(243,606)	(399,550)
Total assets less current liabilities		932,697	871,102
Creditors: Amounts falling due after more than one year	9	(780,722)	(843,104)
Provisions for liabilities		(23,175)	-
Net assets		128,800	27,998
Capital and reserves
Called up share capital	10	100	100
Retained earnings		128,700	27,898
Shareholders' funds		128,800	27,998

For the financial year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 8 October 2025 and signed on its behalf by:
 

......................................... Michael Brown Hutchison Director

H & C Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 May 2025

1	General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
10 Creran Drive
Denny
FK6 5LT

The principal place of business is:
Denny Pharmacy
1 Stirling Street
Denny
FK6 6EL

These financial statements were authorised for issue by the Board on 8 October 2025.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

H & C Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 May 2025

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Fixtures, fittings, equipment	10-25% reducing balance basis p.a.
Motor vehicles	based on year- end approximate market value.
Freehold property	no depreciation required

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

H & C Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 May 2025

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class	Amortisation method and rate
Goodwill	6.5% amortisation straight line basis p.a.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

H & C Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 May 2025

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 14 (2024 - 17).

4	Profit before tax

Arrived at after charging/(crediting)

	2025 £	2024 £
Depreciation expense	18,999	14,953
Amortisation expense	80,050	80,050

5	Intangible assets

	Goodwill  £	Total £
Cost or valuation
At 1 June 2024	1,231,552	1,231,552
At 31 May 2025	1,231,552	1,231,552
Amortisation
At 1 June 2024	80,050	80,050
Amortisation charge	80,050	80,050
At 31 May 2025	160,100	160,100
Carrying amount
At 31 May 2025	1,071,452	1,071,452
At 31 May 2024	1,151,502	1,151,502

H & C Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 May 2025

6	Tangible assets

	Land and buildings £	Furniture, fittings and equipment  £	Motor vehicles  £	Total £
Cost or valuation
At 1 June 2024	12,151	101,957	19,995	134,103
Additions	-	4,700	-	4,700
At 31 May 2025	12,151	106,657	19,995	138,803
Depreciation
At 1 June 2024	-	11,957	2,996	14,953
Charge for the year	-	15,000	3,999	18,999
At 31 May 2025	-	26,957	6,995	33,952
Carrying amount
At 31 May 2025	12,151	79,700	13,000	104,851
At 31 May 2024	12,151	90,000	16,999	119,150

7

Stocks

	2025 £	2024 £
Stock for sale and business use	108,891	48,922

8

Debtors

Current	2025 £	2024 £
Trade debtors	172,298	158,947
Other debtors	6,049	9,648
	178,347	168,595

9

Creditors

Creditors: amounts falling due within one year

	Note	2025 £	2024 £
Due within one year
Loans and borrowings	11	92,777	43,295
Trade creditors		330,696	185,895
Taxation and social security		30,884	(19,105)
Accruals and deferred income		3,000	-
Other creditors		443,556	548,401
		900,913	758,486

H & C Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 May 2025

Creditors: amounts falling due after more than one year

	Note	2025 £	2024 £
Due after one year
Loans and borrowings	11	780,722	843,104

10	Share capital

Allotted, called up and fully paid shares

	2025		2024
	No.	£	No.	£
Ordinary shares of £1 each	100	100	100	100

11	Loans and borrowings

Non-current loans and borrowings

	2025 £	2024 £
Bank borrowings	762,573	805,734
Hire purchase contracts	18,149	37,370
	780,722	843,104

Current loans and borrowings

	2025 £	2024 £
Bank borrowings	20,000	20,000
Hire purchase contracts	19,222	19,222
Director current account	53,555	4,073
	92,777	43,295